|
BRNS Barinthus Biotherapeutics PLC - ADR 1828185 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-5,531,000.00 |
| Balance Sheet |
|
Current Assets
|
$72,664,000.00 |
|
Assets
|
$92,143,000.00 |
|
Current Liabilities
|
$12,001,000.00 |
|
Liabilities
|
$25,665,000.00 |
|
Equity
|
$66,399,000.00 |
|
Shares Out
|
40848893.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,366,000.00 |
|
Investing Cash Flow
|
$55,000.00 |
| Market Analysis |
Market Cap
|
$22,875,380.08 |
|
Price
|
$0.55 |
|
BVPS
|
1.63 |
|
PB
|
0.34 |
|
EPS
|
-0.14 |
|
FCF
|
$-3,366,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:41 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BRNS documents filed with the SEC.
BRNS Filings
Clear
